You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tasquinimod

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Castration-Resistant Trial in China, Korea, Republic of, Taiwan (Tasquinimod, Placebo)

Terminated
Has Results
  • Prostatic Neoplasms, Castration-Resistant
  • Tasquinimod
  • Placebo
  • Beijing, Beijing, China
  • +35 more
Mar 24, 2021

Metastatic Castrate Resistant Prostate Cancer Trial in Worldwide (Tasquinimod, Placebo)

Terminated
Has Results
  • Metastatic Castrate Resistant Prostate Cancer
  • Tasquinimod
  • Placebo
  • Gent, Belgium
  • +57 more
Nov 21, 2019

Advanced or Metastatic Hepatocellular Cancer, Advanced or Metastatic Ovarian Cancer, Metastatic Renal Cell Cancer Trial in

Completed
Has Results
  • Advanced or Metastatic Hepatocellular Cancer
  • +3 more
  • Tasquinimod
  • Edegem, Belgium
  • +23 more
Jan 4, 2019

Prostate Cancer Trial in Chicago, Durham (tasquinimod, tasquinimod 0.25 mg; 0.5 mg, tasquinimod 0.25 mg; 0.5 mg; 1.0 mg)

Completed
  • Prostate Cancer
  • tasquinimod
  • +2 more
  • Chicago, Illinois
  • +1 more
Aug 31, 2018

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Buffalo (other,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 19, 2016

Prostate Cancer, Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC) Trial in Baltimore (Tasquinimod, Radium 223)

Withdrawn
  • Prostate Cancer
  • Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
  • Tasquinimod
  • Radium 223
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 17, 2015

Prostate Cancer Trial in Worldwide (tasquinimod, Placebo)

Completed
  • Prostate Cancer
  • tasquinimod
  • Placebo
  • Tucson, Arizona
  • +204 more
Oct 2, 2015